Healthcare -
Biotechnology - NYSE - US
$ 6.45
-6.79 %
$ 374 M
Market Cap
-0.61
P/E
DNA - REVENUE
Revenue DNA - Ginkgo Bioworks Holdings, Inc.
227 M
LAST VALUE
-31.06%
2 YEAR CAGR
33.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR